Image from Google Jackets

Antiphospholipid Antibody Syndrome, Myasthenia Gravis, and Diabetes Mellitus: A Mosaic of Autoimmune Entities in A Pregnant Patient

By: Language: English Producer: 2012Content type:
  • Text
Media type:
  • Unmediated
Carrier type:
  • Volume
LOC classification:
  • RES OB-GYNE 2012 0001
Dissertation note: MEDICINE Research project Summary: This is a case of a 34-year old, Gravida 5 Para 0 (0040), Pregnancy Uterine 36 weeks, in breech presentation, who presented with poor obstetrical history, she was diagnosed with Antiphospholipid antibody Syndrome. Myasthenia Gravis, and Gestational Diabetes Mellitus-Insulin requiring, and was admitted due to preterm labor. The patient was given the standard management for these clinical entities. For APAS low molecular weight and low dose aspirin, for myasthenia Gravis Pyridostigmine, and for Gestational Diabetes Mellitus, fetal suerveillance via weekly BPS and NST, CBG monitoring, and insulin. The patient was tocolysed with calcium channel blocker (Nifedine) until she reach 38 weeks wherein she then underwent low segment cesarean section which resulted to ag ood baby outcome. APAS and Myasthenia Gravis, the two being autoimmune in origin, are due to the presence of autoantiboides. Therefore the possibilility that her Gestational Diabetes Mellitus could also be of autoimmune origin was considered.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
Research Far Eastern University - Nicanor Reyes Medical Foundation Research OB20120001 (Browse shelf(Opens below)) Available R000370

MEDICINE Research project

This is a case of a 34-year old, Gravida 5 Para 0 (0040), Pregnancy Uterine 36 weeks, in breech presentation, who presented with poor obstetrical history, she was diagnosed with Antiphospholipid antibody Syndrome. Myasthenia Gravis, and Gestational Diabetes Mellitus-Insulin requiring, and was admitted due to preterm labor. The patient was given the standard management for these clinical entities. For APAS low molecular weight and low dose aspirin, for myasthenia Gravis Pyridostigmine, and for Gestational Diabetes Mellitus, fetal suerveillance via weekly BPS and NST, CBG monitoring, and insulin. The patient was tocolysed with calcium channel blocker (Nifedine) until she reach 38 weeks wherein she then underwent low segment cesarean section which resulted to ag ood baby outcome. APAS and Myasthenia Gravis, the two being autoimmune in origin, are due to the presence of autoantiboides. Therefore the possibilility that her Gestational Diabetes Mellitus could also be of autoimmune origin was considered.

There are no comments on this title.

to post a comment.